기자명 Kim Chan-hyuk
Published 2021.03.03
Hyundai Pharm made it official that it will supply Mifegyne, an abortive drug, in Korea. Industry watchers said the supply could open ways for medication abortion.
However, as the company is preparing for the regulator’s preliminary review before seeking the nod, it will take a considerable time until a pregnant woman gets a Mifegyne prescription, observers said.
Continued: http://www.koreabiomed.com/news/articleView.html?idxno=10578